Document is current
Any future updates will be listed below
-
Authors
Ali, Mohamed
Ciebiera, Michał
Wlodarczyk, Marta
Alkhrait, Samar
Maajid, Elise
Yang, Qiwei
Hsia, Shih-Min
Al-Hendy, Ayman
-
Funding
Funding for this research was provided by:
National Institutes of Health (RO1 HD094378; RO1 ES028615; U54 MD007602)
National Institutes of Health (RO1 HD094380)
National Institutes of Health (HD087417)
National Institutes of Health (HD106285.)
- License Information
-
More Information
Article History
Accepted: 9 October 2023
First Online: 3 November 2023
Declarations
:
: This study and open access fee were supported in part by National Institutes of Health grants RO1 HD094378; RO1 ES028615; U54 MD007602, RO1 HD094380, HD087417, and HD106285.
: Ayman Al-Hendy is a consultant for Myovant and Pfizer. Mohamed Ali, Michał Ciebiera, Marta Wlodarczyk, Samar Alkhrait, Elise Maajid, Qiwei Yang, and Shih-Min Hsia declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Public domain as manuscript is review article.
: Conceptualization, MA and AAH; data curation, MA, MC, MW, and SA; writing, original draft and outline preparation, MA, MC, MW, and SA; writing, review and editing, QY, EM, S-MH, and AAH; visualization, MA and AAH; funding acquisition, AAH. All authors have read and approve the final version of the manuscript, and agree to be accountable for the work.
